Sensitive Measurement of Thrombopoietin by a Monoclonal Antibody Based Sandwich Enzyme-linked Immunosorbent Assay

Summary In this report a sensitive enzyme-linked immunosorbent assay (ELISA) for the measurement of plasma thrombopoietin (Tpo) is described that is solely based on monoclonal antibodies (MoAbs). The assay has an intra and inter-assay variance of 5-7% and 7-13%, respectively. Native and recombinant human Tpo (rhTpo) were recognized equally well, no cross reactivity with other cytokines was found and rhTpo added to plasma and serum was completely recovered. With the ELISA, Tpo concentrations in EDTA-anticoagulated plasma of all controls (n = 193) could be determined, since the limit of detection (2 ± 0.8 A.U./ml, mean ± sd) was lower than the concentration found in controls (11 ± 8 A.U./ml, mean ± sd; 2.5th-97.5th percentile: 4-32 A.U./ml). Tpo levels in serum were on average 3.4 times higher than in plasma. We showed in vivo that Tpo is bound by platelets, as in thrombocytopenic patients (n = 5) a platelet transfusion immediately led to a drop in plasma Tpo level, whereas in patients receiving chemotherapy the induced thrombocytopenia was followed by a rise in plasma Tpo levels. In summary, these results indicate that this ELISA is a reliable tool for Tpo measurements and is applicable for large scale studies.

[1]  A. Matsumoto,et al.  A sensitive sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with haemopoietic disorders , 1996, British journal of haematology.

[2]  N. Young,et al.  Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. , 1996, Blood.

[3]  A. Gurney,et al.  Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. , 1996, Blood.

[4]  S. Hanson,et al.  Regulation of platelet production and function by megakaryocyte growth and development factor in nonhuman primates. , 1996, Blood.

[5]  T. Nagasawa,et al.  Bone marrow stromal cells produce thrombopoietin and stimulate megakaryocyte growth and maturation but suppress proplatelet formation. , 1996, Blood.

[6]  R. Skoda,et al.  Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. , 1996, Blood.

[7]  T. Boone,et al.  Megakaryocyte growth and development factor ameliorates carboplatin-induced thrombocytopenia in mice. , 1995, Blood.

[8]  T. Kato,et al.  Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia. , 1995, The Journal of clinical investigation.

[9]  R. Rosenberg,et al.  The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. , 1995, Blood.

[10]  K. Yasukawa,et al.  Influence of interleukin‐6 (IL‐6) autoantibodies on IL‐6 binding to cellular receptors , 1995, European journal of immunology.

[11]  W. Vainchenker,et al.  The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. , 1995, Blood.

[12]  F. Grant,et al.  Human thrombopoietin: gene structure, cDNA sequence, expression, and chromosomal localization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Rosenberg,et al.  Appearance of a megakaryocyte growth-promoting activity, megapoietin, during acute thrombocytopenia in the rabbit. , 1994, Blood.

[14]  V. Broudy,et al.  Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin , 1994, Nature.

[15]  William Vainchenker,et al.  c-Mpl ligand is a humoral regulator of megakaryocytopoiesis , 1994, Nature.

[16]  D. Goeddel,et al.  Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand , 1994, Nature.

[17]  Scott R. Presnell,et al.  Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo , 1994, Nature.

[18]  K. Bendtzen,et al.  Binding of cytokines to pharmaceutically prepared human immunoglobulin. , 1993, The Journal of clinical investigation.

[19]  J. Mornon,et al.  Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. D. de Vos,et al.  Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: synovial fluids and sera. , 1991, Journal of immunological methods.

[21]  K. Bendtzen,et al.  Auto‐Antibodies to Tumour Necrosis Factor a in Healthy Humans and Patients with Inflammatory Diseases and Gram‐Negative Bacterial Infections , 1989, Scandinavian journal of immunology.

[22]  F. Greenwood,et al.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. , 1963, The Biochemical journal.

[23]  Y. Matsuzawa,et al.  Coexpression of thrombopoietin and c-mpl genes in human acute myeloblastic leukemia cells. , 1996, Leukemia.

[24]  H. Lu,et al.  Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. , 1994, Cell.